Antimicrobial Agents Practice Questions

Q: Why is ceftriaxone preferred over penicillin for gonorrhea treatment despite both being effective in vitro?

Lower resistance rates. ***Lower resistance rates*** - The **primary reason** ceftriaxone is preferred over penicillin for gonorrhea is the **widespread emergence of penicillinase-producing *Neisseria gonorrhoeae* (PPNG)** strains and chromosomally-mediated resistance - Penicillin resistance in *N. gonorrhoeae* now exceeds **50-90%** in many regions globally, making penicillin ineffective for empirical treatment - **Ceftriaxone** and other third-generation cephalosporins maintain **high efficacy** against most gonorrhea strains, though emerging cephalosporin resistance is a growing concern - Current **CDC and WHO guidelines** recommend ceftriaxone as first-line therapy specifically because of superior antimicrobial activity against resistant strains *Single-dose convenience* - While ceftriaxone's **single intramuscular dose** regimen does improve patient adherence and treatment completion, this is a **secondary advantage** - Convenience is clinically irrelevant if the drug is ineffective due to resistance - The single-dose feature enhances the utility of ceftriaxone but is not the fundamental reason for its preference over penicillin *Lower risk of allergic reactions* - Ceftriaxone does not have a significantly lower risk of allergic reactions compared to penicillin - Both penicillins and cephalosporins share a **beta-lactam structure**, leading to potential **cross-reactivity** (5-10% in penicillin-allergic patients) - Allergy considerations are important for individual patient selection but do not explain the population-level preference for ceftriaxone *Better tissue penetration* - Both **ceftriaxone** and penicillin achieve adequate tissue penetration at sites of gonorrheal infection (urethra, cervix, rectum, pharynx) - Ceftriaxone does have excellent CNS penetration and longer half-life, but tissue penetration differences are **not the primary factor** in choosing it over penicillin for uncomplicated gonorrhea

Q: A 30-year-old woman presents with breakthrough genital herpes outbreaks despite appropriate suppressive therapy. She is HIV-negative and reports adherence to medication. What is the most likely explanation?

Acyclovir-resistant HSV strain. **Acyclovir-resistant HSV strain** - Given recurrent outbreaks despite suppressive therapy and reported adherence, **drug resistance (e.g., acyclovir resistance)** is the most likely explanation for treatment failure [1]. - Acyclovir resistance typically occurs due to mutations in the **viral thymidine kinase gene**, preventing activation of the drug [1]. *Immunologic factors reducing drug efficacy* - While underlying immune status can affect herpes recurrence, the patient is **HIV-negative**, suggesting a relatively intact immune system. - Suppressive therapy is designed to overcome standard immune responses, so general immunologic factors alone are less likely to cause complete suppressive failure in an otherwise healthy individual [2]. *Incorrect diagnosis of herpes* - Recurrent genital lesions often lead to a high suspicion of herpes, and the initiation of suppressive therapy implies a **prior clinical diagnosis**. - While misdiagnosis is possible, given the history of recurrent outbreaks and *initiation of suppressive therapy*, an incorrect diagnosis is less probable than resistance when the treatment itself is failing. *Superinfection with a different HSV type* - While possible, superinfection with another HSV type (e.g., HSV-1 if initially HSV-2, or vice versa) would typically present with **new primary-like symptoms** or a renewed pattern of outbreaks, not necessarily a direct failure of *ongoing suppressive therapy* for the existing type. - Suppressive therapy against one HSV type usually offers *some cross-protection* or at least would not completely fail against the *original* type due to a new infection.

Q: Which oral antibiotic is contraindicated in pregnant women with chlamydial infection?

Doxycycline. ***Doxycycline*** - **Doxycycline** is contraindicated in pregnant women due to its potential to cause **permanent tooth discoloration** (yellow-brown staining) and **enamel hypoplasia** in the fetus. - It can also inhibit **bone growth** if used during pregnancy, making it an unsuitable choice for chlamydial infection in this population. *Azithromycin* - **Azithromycin** is generally considered safe and is a recommended treatment for **chlamydial infection in pregnant women**. - It is a **macrolide antibiotic** and does not have the teratogenic effects associated with tetracyclines like doxycycline. *Amoxicillin* - **Amoxicillin** is a **penicillin-class antibiotic** and is considered safe for use during pregnancy. - While it can be used for some infections in pregnancy, it is not the primary treatment for **chlamydial infections**, for which macrolides are preferred. *Erythromycin* - **Erythromycin** is another **macrolide antibiotic** that is considered safe for use in pregnant women. - It is an alternative treatment option for **chlamydial infection during pregnancy**, particularly if azithromycin is not tolerated.

Q: What is the mechanism of action of acyclovir in treating herpes infections?

Inhibits viral DNA polymerase after phosphorylation. ***Inhibits viral DNA polymerase after phosphorylation*** - Acyclovir is a **prodrug** that requires activation by viral thymidine kinase, converting it to acyclovir monophosphate. - Subsequent phosphorylation by cellular enzymes forms acyclovir triphosphate, which then competitively inhibits and **inactivates viral DNA polymerase**, terminating DNA chain synthesis. *Inhibits viral reverse transcriptase* - **Reverse transcriptase inhibitors** are primarily used in the treatment of **HIV infections**, as HIV is a retrovirus that utilizes reverse transcriptase for replication. - Herpesviruses are DNA viruses and their replication does not involve a reverse transcriptase enzyme. *Prevents viral attachment to host cells* - This mechanism is characteristic of some **antiviral drugs** that target viral glycoproteins or host cell receptors to block the initial step of infection. - Acyclovir primarily acts intracellularly once the virus has already entered the host cell. *Blocks release of mature virions* - This mechanism is seen with **neuraminidase inhibitors** used for **influenza**, which prevent the budding and release of new viral particles from infected cells. - Acyclovir's action occurs earlier in the viral replication cycle, specifically at the DNA synthesis stage.

Q: Which nomogram scale is used for aminoglycoside dosage?

Hartford nomogram. ***Hartford nomogram*** - The **Hartford nomogram** is the standard tool for determining **once-daily (extended-interval) aminoglycoside dosing** based on **creatinine clearance**. - It helps clinicians optimize aminoglycoside therapy by allowing for less frequent dosing while maintaining therapeutic drug levels and minimizing **nephrotoxicity** and **ototoxicity**. - Developed at Hartford Hospital, this nomogram guides dosing intervals (24, 36, or 48 hours) based on a single serum level drawn 6-14 hours post-dose. *Hallstead scale* - The **Hallstead scale** is not a standard nomogram used in clinical practice for drug dosing. - This term does not correspond to a recognized clinical tool for medication management or aminoglycoside therapy. *Salazar scale* - The **Salazar-Corcoran equation** is used for estimating **creatinine clearance in obese patients**, not as a nomogram for aminoglycoside dosing. - While it may be used in the pharmacokinetic assessment before aminoglycoside dosing, it is not a dosing nomogram itself. *Rumack Matthew nomogram* - The **Rumack-Matthew nomogram** is used for assessing the risk of **hepatotoxicity** after an **acetaminophen overdose** by plotting plasma acetaminophen levels against time. - It is not used for aminoglycoside dosage or therapeutic drug monitoring.

Q: Antimicrobial combinations are used in all except

Gonorrhea. ***Gonorrhea*** - While **gonorrhea** treatment has evolved to include **dual therapy** (e.g., ceftriaxone + azithromycin), this is primarily for co-treatment of potential Chlamydia co-infection and to combat emerging resistance, given as a **single-session treatment**. - Unlike the other conditions, gonorrhea does not require a **prolonged multi-drug regimen** with true synergy or prevention of resistance development during treatment. - The combination is more about empiric co-coverage and resistance concerns rather than the classic indications for antimicrobial combinations (synergy, preventing resistance emergence during therapy, polymicrobial coverage). - This distinguishes it from conditions requiring extended combination therapy. *Intra-abdominal infections* - Involve **polymicrobial etiology** requiring combination therapy to cover both aerobic (e.g., Enterobacteriaceae) and anaerobic bacteria (e.g., Bacteroides fragilis). - Combination therapy ensures broad-spectrum coverage for mixed infections and prevents treatment failures in complex intra-abdominal sepsis. *Malaria* - **Artemisinin-based combination therapies (ACTs)** are the standard first-line treatment for uncomplicated *Plasmodium falciparum* malaria. - Combination therapy reduces drug resistance risk and improves cure rates by targeting different mechanisms of action against the parasite. *Tuberculosis* - Treatment always involves **multi-drug regimen** (isoniazid, rifampicin, pyrazinamide, ethambutol) to prevent emergence of drug-resistant strains. - Multi-drug therapy is essential because *Mycobacterium tuberculosis* rapidly develops resistance if exposed to single agents during the prolonged treatment course.

Q: A 31-year-old man presents with dysuria and urethral discharge. Gram stain shows intracellular gram-negative diplococci. Local resistance patterns show 28% quinolone resistance. Which of the following most appropriately guides empiric therapy selection?

Local antimicrobial susceptibility patterns. ***Local antimicrobial susceptibility patterns*** - Understanding local resistance patterns is crucial for selecting effective empiric therapy, especially with the high quinolone resistance (28%) mentioned. - **Empiric therapy** for suspected **gonorrhea** (suggested by intracellular gram-negative diplococci) must target common resistance mechanisms to ensure initial treatment success. *Patient preference* - While patient preferences can influence adherence, they do not guide the initial choice of antibiotic for a serious infection like gonorrhea, which requires an effective agent. - Clinical efficacy and public health considerations for preventing resistance take precedence over patient preference in selecting empiric therapy. *Duration of therapy* - The duration of therapy is determined *after* an effective antibiotic is chosen and is based on the specific infection and organism; it does not guide the initial selection of the drug itself. - Most gonorrhea treatments are single-dose, but this is a consequence of the chosen drug's efficacy rather than a guiding principle for selection. *Route of administration* - While practical for the patient, the route of administration (e.g., oral vs. intramuscular) is a secondary consideration after an effective agent is identified based on susceptibility. - Many empiric gonorrhea treatments include an intramuscular injection for single-dose efficacy, making route less of a primary guide for selection. *Organism identification confirmation* - Waiting for definitive organism identification and susceptibility testing would delay treatment and is inappropriate for symptomatic gonorrhea, which requires immediate empiric therapy. - The Gram stain already provides strong presumptive evidence, and empiric treatment must be initiated based on likely pathogens and local resistance patterns rather than waiting for culture confirmation.

Q: A 35-year-old man with a past medical history of HIV is hospitalized with a disseminated zoster infection and treated with IV acyclovir. His course of illness worsens on the 4th day after admission and his creatinine level increases to 4.2 mg/dL. Urinalysis shows birefringent needle-shaped crystals. What could have prevented this deterioration in the patient's renal function?

Adequate initial hydration. Adequate initial hydration - Intravenous (IV) acyclovir is associated with **nephrotoxicity** due to the formation of **insoluble acyclovir crystals** in the renal tubules, especially in states of dehydration. - **Maintaining adequate hydration** helps in diluting the drug and preventing crystal precipitation, thereby protecting renal function. [1] *Initial administration of allopurinol* - **Allopurinol** is used to prevent **uric acid nephropathy**, typically seen in **tumor lysis syndrome**, not acyclovir-induced crystal nephropathy. [2] - Its administration would not have prevented the formation of **acyclovir crystals**. *Initial administration of glucocorticoids* - **Glucocorticoids** are potent anti-inflammatory agents but do not prevent **drug-induced crystal formation** or directly protect against acyclovir nephrotoxicity. - They are primarily used for inflammatory conditions or to suppress immune responses. *Monitoring of drug levels* - While drug level monitoring can be useful for certain medications to prevent toxicity, it's not the primary preventative measure for **acyclovir-induced crystal nephropathy**. - **Hydration** is more immediate and effective in preventing crystal precipitation. *Obtaining a thorough history of patient allergies* - An allergy history is crucial for preventing **hypersensitivity reactions** to medications, but it would not prevent **nephrotoxicity** due to crystal formation, which is a pharmacokinetic phenomenon. - The patient's renal deterioration is due to **acyclovir crystal nephropathy**, not an allergic reaction.

Q: A 30-year-old man presents to his primary care physician for pain in his left ankle. The patient states that he was at karate practice when he suddenly felt severe pain in his ankle forcing him to stop. The patient has a past medical history notable for type I diabetes and is currently being treated for an episode of acute bacterial sinusitis with moxifloxacin. The patient recently had to have his insulin dose increased secondary to poorly controlled blood glucose levels. Otherwise, the patient takes ibuprofen for headaches and loratadine for seasonal allergies. Physical exam reveals a young healthy man in no acute distress. Pain is elicited over the Achilles tendon with dorsiflexion of the left foot. Pain is also elicited with plantar flexion of the left foot against resistance. Which of the following is the best next step in management?

Change antibiotics and refrain from athletic activities. The patient is experiencing **Achilles tendonitis**, likely a side effect of **moxifloxacin**, which is known to cause **tendinopathy** and **tendon rupture**, especially in patients with **diabetes** or those initiating **corticosteroids** [1]. **Discontinuation of moxifloxacin** and avoidance of strenuous activities are crucial to prevent further tendon damage, with alternative antibiotics for sinusitis [1]. *Refrain from athletic activities for 1 to 2 weeks* - While **refraining from activity** is important, it is insufficient on its own because the underlying cause (moxifloxacin) would persist, potentially worsening the tendon injury. - This option does not address the need to **change the causative medication**, which is the primary intervention for fluoroquinolone-induced tendinopathy [1]. *Rehabilitation exercises and activity as tolerated* - **Rehabilitation exercises** are typically introduced in later stages of recovery, after the acute inflammation has subsided and the causative agent is removed. - **Activity as tolerated** is inappropriate when there is a high risk of **tendon rupture** due to drug-induced tendinopathy; initial management requires strict rest. *Ibuprofen and rest* - **Ibuprofen** can help with pain and inflammation, but it does not address the underlying **fluoroquinolone-induced tendinopathy**. - While **rest** is important, the continued use of moxifloxacin would still predispose the patient to further tendon injury or rupture, making simply resting an incomplete solution.

Q: Drug of choice for nasal carriers of MRSA is:

Mupirocin. ***Mupirocin*** - **Mupirocin** (Bactroban) is a **topical antibacterial agent** frequently used for the eradication of **nasal colonization with MRSA**. - It is applied directly to the **nares** and works by inhibiting bacterial protein synthesis. *Linezolid* - **Linezolid** is an **oral** or **intravenous antibiotic** used for systemic MRSA infections, not typically for nasal decolonization. - Its use for nasal carriage would be inappropriate due to the risk of systemic side effects and potential for resistance development. *Vancomycin* - **Vancomycin** is a **glycopeptide antibiotic** administered intravenously for severe MRSA infections, not for nasal decolonization. - It has poor oral bioavailability and is not effective as a topical agent for nasal carriage. *Teicoplanin* - **Teicoplanin** is another **glycopeptide antibiotic** similar to vancomycin, used for systemic MRSA infections. - Like vancomycin, it is not used for the topical eradication of nasal MRSA colonization.

Question 1

Why is ceftriaxone preferred over penicillin for gonorrhea treatment despite both being effective in vitro?

Accepted Answer

Lower resistance rates

Answer

Single-dose convenience

Answer

Better tissue penetration

Answer

Lower risk of allergic reactions

Question 2

A 30-year-old woman presents with breakthrough genital herpes outbreaks despite appropriate suppressive therapy. She is HIV-negative and reports adherence to medication. What is the most likely explanation?

Accepted Answer

Acyclovir-resistant HSV strain

Answer

Immunologic factors reducing drug efficacy

Answer

Incorrect diagnosis of herpes

Answer

Superinfection with a different HSV type

Question 3

Which oral antibiotic is contraindicated in pregnant women with chlamydial infection?

Accepted Answer

Doxycycline

Answer

Azithromycin

Answer

Amoxicillin

Answer

Erythromycin

Question 4

What is the mechanism of action of acyclovir in treating herpes infections?

Accepted Answer

Inhibits viral DNA polymerase after phosphorylation

Answer

Inhibits viral reverse transcriptase

Answer

Prevents viral attachment to host cells

Answer

Blocks release of mature virions

Question 5

Which nomogram scale is used for aminoglycoside dosage?

Accepted Answer

Hartford nomogram

Answer

Hallstead scale

Answer

Salazar scale

Answer

Rumack Matthew nomogram

Question 6

Antimicrobial combinations are used in all except

Accepted Answer

Gonorrhea

Answer

Intra abdominal infections

Answer

Malaria

Answer

Tuberculosis

Question 7

A 31-year-old man presents with dysuria and urethral discharge. Gram stain shows intracellular gram-negative diplococci. Local resistance patterns show 28% quinolone resistance. Which of the following most appropriately guides empiric therapy selection?

Accepted Answer

Local antimicrobial susceptibility patterns

Answer

Patient preference

Answer

Duration of therapy

Answer

Route of administration

Answer

Organism identification confirmation

Question 8

A 35-year-old man with a past medical history of HIV is hospitalized with a disseminated zoster infection and treated with IV acyclovir. His course of illness worsens on the 4th day after admission and his creatinine level increases to 4.2 mg/dL. Urinalysis shows birefringent needle-shaped crystals. What could have prevented this deterioration in the patient's renal function?

Accepted Answer

Adequate initial hydration

Answer

Initial administration of allopurinol

Answer

Initial administration of glucocorticoids

Answer

Monitoring of drug levels

Answer

Obtaining a thorough history of patient allergies

Question 9

A 30-year-old man presents to his primary care physician for pain in his left ankle. The patient states that he was at karate practice when he suddenly felt severe pain in his ankle forcing him to stop. The patient has a past medical history notable for type I diabetes and is currently being treated for an episode of acute bacterial sinusitis with moxifloxacin. The patient recently had to have his insulin dose increased secondary to poorly controlled blood glucose levels. Otherwise, the patient takes ibuprofen for headaches and loratadine for seasonal allergies. Physical exam reveals a young healthy man in no acute distress. Pain is elicited over the Achilles tendon with dorsiflexion of the left foot. Pain is also elicited with plantar flexion of the left foot against resistance. Which of the following is the best next step in management?

Accepted Answer

Change antibiotics and refrain from athletic activities

Answer

Refrain from athletic activities for 1 to 2 weeks

Answer

Rehabilitation exercises and activity as tolerated

Answer

Ibuprofen and rest

Question 10

Drug of choice for nasal carriers of MRSA is:

Accepted Answer

Mupirocin

Answer

Linezolid

Answer

Vancomycin

Answer

Teicoplanin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?